data_2dvj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dvj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' CE ' ' H ' ' A' ' 2' ' ' ALA . 3.2 tpt . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.855 0.36 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' H ' ' CE ' ' A' ' 1' ' ' MET . . . 71.88 -61.25 0.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.25 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.05 51.06 0.83 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.356 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.06 38.66 1.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.887 0.375 . . . . 0.0 110.947 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -120.77 117.7 28.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.97 166.31 13.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -94.27 -15.36 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.244 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 31.01 6.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.716 0.294 . . . . 0.0 111.549 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -108.44 -18.85 13.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 40.08 32.84 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.196 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -132.56 -42.18 0.94 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -31.87 10.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.414 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.555 ' CZ3' ' CG2' ' A' ' 37' ' ' VAL . 14.7 p-90 -93.23 -15.44 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.505 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -112.61 112.45 23.98 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.758 0.314 . . . . 0.0 111.326 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.426 ' CG ' HD12 ' A' ' 18' ' ' LEU . 15.6 m95 -79.48 -17.38 54.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.616 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.59 -107.78 3.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 58.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 111.19 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -79.79 141.22 36.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -61.42 146.44 48.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -22.23 61.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.71 -25.69 15.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.021 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.63 -22.43 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.179 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 36' ' ' LEU . . . -79.06 -21.67 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.983 0.421 . . . . 0.0 110.859 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.621 HG21 HG13 ' A' ' 57' ' ' VAL . 7.6 p -102.91 -27.3 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.047 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.12 72.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.395 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -95.44 -45.3 7.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.165 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.569 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 25.6 tp -63.76 -53.94 43.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 110.767 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -55.65 110.99 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.386 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.02 36.23 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.76 -0.733 . . . . 0.0 114.389 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.58 ' HG3' ' CG2' ' A' ' 118' ' ' VAL . 12.9 mm-40 -69.16 -60.32 2.43 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.925 0.862 . . . . 0.0 111.435 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.49 ' HG2' HG22 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -159.04 -148.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.009 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.72 -35.07 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.739 0.304 . . . . 0.0 110.997 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -150.37 125.45 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.791 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.635 ' CG1' ' HB ' ' A' ' 118' ' ' VAL . 22.0 t -156.04 158.83 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' N ' HG11 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -158.04 162.59 38.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.958 0.409 . . . . 0.0 111.487 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' ' 27' ' ' LEU . 3.6 pp -154.08 -169.32 3.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.217 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG2' ' CZ3' ' A' ' 13' ' ' TRP . 0.1 OUTLIER -146.83 137.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.731 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -174.14 2.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.67 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -120.18 -2.1 10.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.614 0.245 . . . . 0.0 111.095 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t 57.15 110.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.031 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.4 m -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.17 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.8 m -71.81 -33.89 68.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.45 67.95 0.93 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.597 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.51 -29.61 79.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.69 2.26 . . . . 0.0 112.214 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.12 -18.52 60.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.469 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 6.9 m-20 -109.01 127.94 54.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 62' ' ' ILE . 6.4 m-85 -89.01 163.19 15.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.044 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -129.62 155.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.508 ' CD1' HG12 ' A' ' 51' ' ' VAL . 1.7 tm? -120.82 118.4 29.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.4 t -103.65 141.37 36.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.25 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG12 ' CD1' ' A' ' 49' ' ' LEU . 33.1 m -140.45 94.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.151 0.5 . . . . 0.0 112.206 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.0 t -35.84 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.408 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.51 -82.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.881 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -109.81 -142.23 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -33.41 -68.21 0.11 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.172 0.442 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -164.75 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG13 HG21 ' A' ' 24' ' ' VAL . 26.5 m -99.73 -152.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.29 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.45 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -134.81 88.63 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.237 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -66.53 119.15 11.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.44 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CD1' ' HD3' ' A' ' 224' ' ' PRO . 30.0 m-85 -123.97 126.17 45.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.053 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.515 HG12 ' CG ' ' A' ' 221' ' ' PTR . 0.0 OUTLIER -87.99 121.41 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.371 0.605 . . . . 0.0 111.757 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 63' ' ' ASN . 2.4 mp -98.15 162.56 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.113 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' A' ' 62' ' ' ILE . 3.4 m-80 -131.99 129.36 40.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 111.397 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.22 89.13 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.515 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -75.1 -6.42 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 86' ' ' ARG . . . 65.06 136.84 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.178 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.36 87.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.499 2.133 . . . . 0.0 112.328 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -149.13 123.37 4.72 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.61 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.2 Cg_exo -58.99 -175.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.218 1.945 . . . . 0.0 111.789 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' O ' HG23 ' A' ' 71' ' ' VAL . 69.0 Cg_endo -83.53 102.28 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.58 2.187 . . . . 0.0 113.345 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 70' ' ' PRO . 2.1 m 102.33 -41.3 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.031 1.332 . . . . 0.0 113.799 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 44.0 Cg_endo -91.21 167.49 3.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.994 1.796 . . . . 0.0 112.633 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.39 -47.33 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.528 2.152 . . . . 0.0 112.264 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 1.3 m 172.63 65.44 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 74' ' ' SER . 7.5 Cg_exo -72.97 -42.01 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.397 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.08 98.39 6.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.605 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.605 ' HB2' ' HD3' ' A' ' 78' ' ' PRO . 25.1 mm-40 -160.99 -59.33 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 77' ' ' GLN . 63.1 Cg_exo -50.78 -50.65 13.11 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.211 1.941 . . . . 0.0 113.627 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 78' ' ' PRO . 2.2 Cg_endo -43.13 -59.84 0.91 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.934 2.423 . . . . 0.0 113.874 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.446 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -64.6 -19.28 64.76 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.186 1.924 . . . . 0.0 112.633 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.17 -54.18 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.954 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 35.2 m -76.52 87.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.237 0.541 . . . . 0.0 110.831 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 t -113.07 103.4 55.64 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.628 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.43 167.03 25.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.541 2.16 . . . . 0.0 112.458 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.82 -171.72 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HB2' ' N ' ' A' ' 66' ' ' GLY . 29.6 mmt180 -126.72 104.03 7.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' CD1' ' CD2' ' A' ' 100' ' ' LEU . 2.9 tm? -149.29 117.43 6.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 21.3 ttp180 -131.4 134.13 45.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.468 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.567 ' CG2' ' H ' ' A' ' 90' ' ' GLY . 8.9 tt -91.98 -96.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.156 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.567 ' H ' ' CG2' ' A' ' 89' ' ' ILE . . . -84.63 -77.34 1.17 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.932 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' CB ' ' CB ' ' A' ' 225' ' ' SER . 23.1 t70 -120.56 -32.25 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 110.945 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.89 132.1 38.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -124.02 159.95 28.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.307 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -147.27 -115.79 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.58 -69.26 0.83 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 m -125.29 -162.11 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.4 mm? -74.95 -62.18 0.92 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.784 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 13' ' ' TRP . 4.4 Cg_endo -46.66 -23.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.887 2.391 . . . . 0.0 112.426 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.79 -33.98 69.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -97.22 -7.16 32.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.593 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 23.2 mt -76.73 -35.82 57.54 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.462 0.649 . . . . 0.0 109.614 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -12.12 49.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -77.59 -23.44 49.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.414 ' CG ' ' HB3' ' A' ' 109' ' ' LEU . 66.8 m-85 -119.64 19.01 12.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.332 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.654 ' HA ' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -63.21 -20.71 65.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -156.45 33.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.602 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.73 -6.21 8.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.177 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 111' ' ' THR . 0.4 OUTLIER 63.23 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.661 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.496 ' HB2' ' CB ' ' A' ' 224' ' ' PRO . 0.8 OUTLIER -77.36 -44.18 30.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.825 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 111' ' ' THR . 3.3 t0 -139.69 -17.06 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.563 ' CB ' ' O ' ' A' ' 110' ' ' ASP . 8.6 t 139.46 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.401 0.68 . . . . 0.0 110.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 t 170.6 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.416 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER 61.27 157.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.654 ' HB3' ' HA ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -89.64 136.22 33.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.195 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.59 ' CG2' ' H ' ' A' ' 116' ' ' GLU . 2.5 mm -121.25 -158.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.122 0.487 . . . . 0.0 111.72 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.59 ' H ' ' CG2' ' A' ' 115' ' ' ILE . 5.7 pt-20 -81.15 158.29 69.9 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.295 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.38 143.1 81.63 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.177 . . . . 0.0 112.121 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.635 ' HB ' ' CG1' ' A' ' 34' ' ' VAL . 5.9 p -73.52 -49.49 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 61.5 m 58.09 -165.97 0.16 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.75 -33.61 76.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 122' ' ' ARG . 1.0 OUTLIER 66.48 -65.01 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.505 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.463 ' N ' ' OG ' ' A' ' 121' ' ' SER . 20.2 ttp-105 -174.57 -102.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.538 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.456 ' CG ' ' HG2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -140.47 -76.29 0.32 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.761 0.315 . . . . 0.0 111.03 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.47 105.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.445 ' HA ' ' CH2' ' A' ' 169' ' ' TRP . 14.6 p -55.45 -89.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.566 0.222 . . . . 0.0 111.165 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.43 34.9 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.58 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 165' ' ' PRO . 1.8 m -57.56 -177.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.265 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.93 178.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.062 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.38 179.65 5.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 50.45 80.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.395 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.88 151.23 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.23 164.98 14.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -147.23 172.54 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.62 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -169.14 160.31 9.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.149 0.499 . . . . 0.0 111.872 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -99.37 135.59 40.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.453 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.549 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 0.0 OUTLIER 166.55 93.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.905 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 158' ' ' ILE . 1.2 m 179.86 140.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.174 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.51 ' O ' ' CD2' ' A' ' 140' ' ' LEU . 6.5 tpt180 -127.85 96.9 4.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.543 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . . . -37.56 160.02 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.173 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.679 ' HG ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -144.36 20.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.895 -178.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -151.13 145.55 25.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.446 0.641 . . . . 0.0 112.451 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.32 77.57 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.564 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -81.58 173.84 11.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.33 -39.38 2.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.026 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.56 150.71 16.42 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.76 -34.82 15.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 -168.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.58 1.01 40.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.462 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 179' ' ' ARG . 9.8 pt-20 -105.04 -38.84 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.322 . . . . 0.0 110.95 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.91 165.88 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' HB3' HG23 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -109.67 111.82 58.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.64 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.697 ' O ' ' CG ' ' A' ' 153' ' ' PHE . 41.8 Cg_endo -89.71 -74.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.183 2.588 . . . . 0.0 112.873 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.697 ' CG ' ' O ' ' A' ' 152' ' ' PRO . 3.7 p90 58.2 162.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.394 0.434 . . . . 0.0 111.052 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.09 179.79 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.381 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 131.98 49.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.138 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.411 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 85.05 46.76 5.51 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.05 132.42 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 11.6 mm -94.68 121.4 45.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.993 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -104.39 161.99 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.687 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.435 ' CD ' ' C ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -103.68 88.15 3.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 171' ' ' ASN . 23.1 mm -56.6 112.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.66 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -77.93 -31.14 50.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.886 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.79 161.65 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.206 0.527 . . . . 0.0 112.116 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.552 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -101.51 83.93 0.49 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.864 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.621 ' HD2' ' HA ' ' A' ' 170' ' ' TRP . 24.8 Cg_endo -64.43 -33.79 56.48 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.436 1.424 . . . . 0.0 110.538 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.472 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -156.23 -167.77 2.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.047 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.68 -11.72 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.12 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 185' ' ' PRO . 6.2 pt20 -91.92 -32.22 15.36 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.785 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.546 ' CD1' ' HG2' ' A' ' 165' ' ' PRO . 0.5 OUTLIER -142.68 141.88 31.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.593 0.711 . . . . 0.0 111.961 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CG ' HG23 ' A' ' 184' ' ' VAL . 38.0 m0 -124.94 103.13 7.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.617 ' N ' ' CE ' ' A' ' 181' ' ' MET . 0.2 OUTLIER -36.4 122.18 0.74 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 163.39 38.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.279 0.562 . . . . 0.0 111.841 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 179' ' ' ARG . 4.2 tt0 -115.39 154.06 29.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.177 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 173' ' ' GLU . 48.4 t0 -96.01 155.4 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.157 0.503 . . . . 0.0 110.952 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 p -59.49 0.39 0.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.842 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -91.65 -32.08 15.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.894 0.378 . . . . 0.0 110.326 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 134.31 -23.89 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.463 ' CD ' ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.35 158.97 25.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.612 ' HA ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -136.36 178.57 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 111.726 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.79 -163.52 34.2 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.617 ' CE ' ' N ' ' A' ' 171' ' ' ASN . 4.9 mmm -97.32 120.25 37.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 170' ' ' TRP . 34.4 pt -93.99 167.02 14.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.337 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 28.1 Cg_endo -86.62 110.78 0.94 Allowed 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.608 2.205 . . . . 0.0 110.067 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.653 HG23 ' CG ' ' A' ' 170' ' ' TRP . 32.7 t -59.41 -56.76 32.63 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.711 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 184' ' ' VAL . 38.2 Cg_endo -66.65 10.0 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.943 1.762 . . . . 0.0 112.765 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.562 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 2.7 m-85 -117.56 -21.94 8.34 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.679 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.4 m -117.75 -171.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 9.8 pt-20 -155.36 -176.44 5.94 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.238 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 135.02 34.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -150.35 126.99 10.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.89 0.376 . . . . 0.0 110.767 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -116.69 92.98 39.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.78 -42.01 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.553 2.169 . . . . 0.0 111.742 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -179.42 34.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.8 t -153.32 47.24 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.72 24.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.477 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.54 -174.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.018 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.63 -174.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.091 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.59 175.83 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -158.73 -45.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.027 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 77.67 -53.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.224 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.41 -30.32 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -94.49 22.39 37.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.593 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.44 90.03 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -112.38 -175.8 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.72 29.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 58.37 68.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.29 -133.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -111.02 -30.32 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.636 ' N ' ' CD ' ' A' ' 210' ' ' PRO . 19.1 p-80 -82.21 -29.65 0.49 Allowed Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 209' ' ' HIS . 63.8 Cg_endo -83.46 -57.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 60.76 149.95 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.89 178.8 5.98 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.77 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 153.52 156.66 7.72 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -50.26 115.05 2.9 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.68 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.7 155.87 66.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.502 2.135 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.519 ' N ' ' HD3' ' A' ' 218' ' ' PRO . 0.5 OUTLIER -142.02 60.93 11.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.888 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 217' ' ' GLU . 24.6 Cg_exo -63.29 67.15 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.992 2.461 . . . . 0.0 112.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -153.55 -177.09 26.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.323 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.46 160.76 46.0 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.444 2.096 . . . . 0.0 112.247 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PTR . . . . . 0.559 ' HD1' ' N ' ' A' ' 221' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 61.53 -162.95 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -156.93 131.57 5.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.601 ' HD3' ' CD1' ' A' ' 60' ' ' TYR . 2.2 Cg_endo -51.65 -22.89 13.98 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.927 1.752 . . . . 0.0 112.454 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.427 ' CB ' ' CB ' ' A' ' 91' ' ' ASP . 12.9 m -114.15 111.91 22.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.6 m -124.36 -45.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -147.41 28.86 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.811 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.902 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 3.2 tpt . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.855 0.36 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 71.88 -61.25 0.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.25 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.05 51.06 0.83 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.356 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -141.06 38.66 1.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.887 0.375 . . . . 0.0 110.947 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -120.77 117.7 28.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.97 166.31 13.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -94.27 -15.36 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.244 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 31.01 6.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.716 0.294 . . . . 0.0 111.549 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -108.44 -18.85 13.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 40.08 32.84 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.196 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -132.56 -42.18 0.94 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -31.87 10.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.414 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.803 ' CZ3' HG21 ' A' ' 37' ' ' VAL . 14.7 p-90 -93.23 -15.44 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.505 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.683 ' HA ' HG23 ' A' ' 37' ' ' VAL . 11.0 t80 -112.61 112.45 23.98 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.758 0.314 . . . . 0.0 111.326 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.779 ' CG ' HD12 ' A' ' 18' ' ' LEU . 15.6 m95 -79.48 -17.38 54.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.616 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.59 -107.78 3.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 58.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 111.19 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -79.79 141.22 36.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -61.42 146.44 48.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -22.23 61.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.517 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 1.6 pt20 -96.71 -25.69 15.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.851 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.5 mm-40 -89.63 -22.43 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.179 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.868 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -79.06 -21.67 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.983 0.421 . . . . 0.0 110.859 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.844 HG23 HG13 ' A' ' 57' ' ' VAL . 7.6 p -102.91 -27.3 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.047 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 21' ' ' GLN . . . -60.42 -33.12 72.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.395 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -95.44 -45.3 7.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.165 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.858 ' N ' HD22 ' A' ' 26' ' ' LEU . 25.6 tp -63.76 -53.94 43.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 110.767 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -55.65 110.99 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.386 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.02 36.23 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.76 -0.733 . . . . 0.0 114.389 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.826 ' HG3' HG23 ' A' ' 118' ' ' VAL . 12.9 mm-40 -69.16 -60.32 2.43 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.925 0.862 . . . . 0.0 111.435 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.511 ' HG2' HG23 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -159.04 -148.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.009 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.72 -35.07 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.739 0.304 . . . . 0.0 110.997 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.812 ' HA3' HG21 ' A' ' 115' ' ' ILE . . . -150.37 125.45 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.791 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.647 ' CG1' ' HB ' ' A' ' 118' ' ' VAL . 22.0 t -156.04 158.83 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.883 ' CE2' HD11 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -158.04 162.59 38.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.958 0.409 . . . . 0.0 111.487 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.848 HD21 ' O ' ' A' ' 23' ' ' ALA . 3.6 pp -154.08 -169.32 3.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.217 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.803 HG21 ' CZ3' ' A' ' 13' ' ' TRP . 0.1 OUTLIER -146.83 137.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.731 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.667 ' HB2' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -117.53 -174.14 2.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.67 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -120.18 -2.1 10.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.614 0.245 . . . . 0.0 111.095 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t 57.15 110.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.031 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.4 m -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.17 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.8 m -71.81 -33.89 68.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.45 67.95 0.93 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.597 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.51 -29.61 79.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.69 2.26 . . . . 0.0 112.214 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.12 -18.52 60.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.469 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 6.9 m-20 -109.01 127.94 54.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.01 163.19 15.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.796 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -129.62 155.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.612 HD11 ' CG1' ' A' ' 51' ' ' VAL . 1.7 tm? -120.82 118.4 29.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.547 ' OG ' HG21 ' A' ' 57' ' ' VAL . 7.4 t -103.65 141.37 36.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.25 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.1 m -140.45 94.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.151 0.5 . . . . 0.0 112.206 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.0 t -35.84 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.408 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.51 -82.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.881 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 55' ' ' SER . 1.5 p-10 -109.81 -142.23 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -33.41 -68.21 0.11 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.172 0.442 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -164.75 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 24' ' ' VAL . 26.5 m -99.73 -152.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.29 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -134.81 88.63 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.237 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 221' ' ' PTR . 14.7 p80 -66.53 119.15 11.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.44 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.603 ' CD1' ' HD3' ' A' ' 224' ' ' PRO . 30.0 m-85 -123.97 126.17 45.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.053 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.533 HG12 ' CG ' ' A' ' 221' ' ' PTR . 0.0 OUTLIER -87.99 121.41 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.371 0.605 . . . . 0.0 111.757 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 49' ' ' LEU . 2.4 mp -98.15 162.56 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.113 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.456 ' N ' HG22 ' A' ' 62' ' ' ILE . 3.4 m-80 -131.99 129.36 40.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 111.397 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.22 89.13 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.515 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -75.1 -6.42 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 86' ' ' ARG . . . 65.06 136.84 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.178 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.36 87.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.499 2.133 . . . . 0.0 112.328 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -149.13 123.37 4.72 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.61 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.2 Cg_exo -58.99 -175.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.218 1.945 . . . . 0.0 111.789 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.805 ' O ' HG13 ' A' ' 71' ' ' VAL . 69.0 Cg_endo -83.53 102.28 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.58 2.187 . . . . 0.0 113.345 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 70' ' ' PRO . 2.1 m 102.33 -41.3 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.031 1.332 . . . . 0.0 113.799 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.769 ' HD3' HG22 ' A' ' 71' ' ' VAL . 44.0 Cg_endo -91.21 167.49 3.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.994 1.796 . . . . 0.0 112.633 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.39 -47.33 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.528 2.152 . . . . 0.0 112.264 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 1.3 m 172.63 65.44 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 74' ' ' SER . 7.5 Cg_exo -72.97 -42.01 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.397 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.08 98.39 6.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.605 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.661 ' HB2' ' HD3' ' A' ' 78' ' ' PRO . 25.1 mm-40 -160.99 -59.33 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 77' ' ' GLN . 63.1 Cg_exo -50.78 -50.65 13.11 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.211 1.941 . . . . 0.0 113.627 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 78' ' ' PRO . 2.2 Cg_endo -43.13 -59.84 0.91 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.934 2.423 . . . . 0.0 113.874 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -64.6 -19.28 64.76 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.186 1.924 . . . . 0.0 112.633 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.17 -54.18 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.954 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.2 m -76.52 87.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.237 0.541 . . . . 0.0 110.831 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 t -113.07 103.4 55.64 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.628 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.43 167.03 25.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.541 2.16 . . . . 0.0 112.458 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.82 -171.72 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB2' ' N ' ' A' ' 66' ' ' GLY . 29.6 mmt180 -126.72 104.03 7.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.779 ' CD1' HD21 ' A' ' 100' ' ' LEU . 2.9 tm? -149.29 117.43 6.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 21.3 ttp180 -131.4 134.13 45.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.468 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.892 HG23 ' H ' ' A' ' 90' ' ' GLY . 8.9 tt -91.98 -96.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.156 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.892 ' H ' HG23 ' A' ' 89' ' ' ILE . . . -84.63 -77.34 1.17 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.932 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' CB ' ' CB ' ' A' ' 225' ' ' SER . 23.1 t70 -120.56 -32.25 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 110.945 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.404 ' NE2' ' OH ' ' A' ' 104' ' ' TYR . 1.9 mt-30 -93.89 132.1 38.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -124.02 159.95 28.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.307 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -147.27 -115.79 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.58 -69.26 0.83 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 m -125.29 -162.11 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 87' ' ' LEU . 1.4 mm? -74.95 -62.18 0.92 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.784 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.479 ' HD3' ' CZ2' ' A' ' 13' ' ' TRP . 4.4 Cg_endo -46.66 -23.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.887 2.391 . . . . 0.0 112.426 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.79 -33.98 69.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.779 HD21 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -97.22 -7.16 32.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.593 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.769 HD11 ' CZ3' ' A' ' 13' ' ' TRP . 23.2 mt -76.73 -35.82 57.54 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.462 0.649 . . . . 0.0 109.614 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -12.12 49.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -77.59 -23.44 49.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.421 ' CG ' ' HB3' ' A' ' 109' ' ' LEU . 66.8 m-85 -119.64 19.01 12.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.332 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -63.21 -20.71 65.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.69 HD13 ' N ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -156.45 33.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.602 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.73 -6.21 8.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.177 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 111' ' ' THR . 0.4 OUTLIER 63.23 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.661 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.805 HD12 ' H ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -77.36 -44.18 30.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.825 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.805 ' H ' HD12 ' A' ' 109' ' ' LEU . 3.3 t0 -139.69 -17.06 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 110' ' ' ASP . 8.6 t 139.46 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.401 0.68 . . . . 0.0 110.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 51' ' ' VAL . 1.2 t 170.6 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.424 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER 61.27 157.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.883 HD11 ' CE2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -89.64 136.22 33.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.195 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.858 HG22 ' H ' ' A' ' 116' ' ' GLU . 2.5 mm -121.25 -158.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.122 0.487 . . . . 0.0 111.72 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.858 ' H ' HG22 ' A' ' 115' ' ' ILE . 5.7 pt-20 -81.15 158.29 69.9 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.295 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.38 143.1 81.63 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.177 . . . . 0.0 112.121 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.826 HG23 ' HG3' ' A' ' 30' ' ' GLN . 5.9 p -73.52 -49.49 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.555 ' N ' HG13 ' A' ' 118' ' ' VAL . 61.5 m 58.09 -165.97 0.16 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.75 -33.61 76.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 122' ' ' ARG . 1.0 OUTLIER 66.48 -65.01 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.505 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.463 ' N ' ' OG ' ' A' ' 121' ' ' SER . 20.2 ttp-105 -174.57 -102.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.538 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.459 ' CG ' ' HG2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -140.47 -76.29 0.32 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.761 0.315 . . . . 0.0 111.03 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.47 105.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' CH2' ' A' ' 169' ' ' TRP . 14.6 p -55.45 -89.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.566 0.222 . . . . 0.0 111.165 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.43 34.9 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.58 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 165' ' ' PRO . 1.8 m -57.56 -177.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.265 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.598 HD11 ' OD2' ' A' ' 163' ' ' ASP . 1.4 pt -98.93 178.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.062 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.38 179.65 5.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 50.45 80.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.395 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.501 ' HB2' HD22 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -175.88 151.23 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.897 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 200' ' ' LEU . 2.6 mm-40 -66.23 164.98 14.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -147.23 172.54 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.62 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -169.14 160.31 9.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.149 0.499 . . . . 0.0 111.872 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 33.3 tt0 -99.37 135.59 40.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.453 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.963 ' O ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER 166.55 93.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.905 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.963 HG13 ' O ' ' A' ' 136' ' ' TYR . 1.2 m 179.86 140.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.174 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.645 ' HA ' HD13 ' A' ' 158' ' ' ILE . 6.5 tpt180 -127.85 96.9 4.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.766 ' HB1' ' CE1' ' A' ' 153' ' ' PHE . . . -37.56 160.02 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.173 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.715 ' HG ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -144.36 20.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.895 -178.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -151.13 145.55 25.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.446 0.641 . . . . 0.0 112.451 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 6.3 p-10 -84.32 77.57 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.564 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -81.58 173.84 11.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.33 -39.38 2.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.026 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.56 150.71 16.42 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.76 -34.82 15.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 -168.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.58 1.01 40.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.462 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 179' ' ' ARG . 9.8 pt-20 -105.04 -38.84 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.322 . . . . 0.0 110.95 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.459 ' OD1' ' NE2' ' A' ' 123' ' ' GLN . 3.4 m-20 -60.91 165.88 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.752 ' HB3' HG22 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -109.67 111.82 58.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.64 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.697 ' O ' ' CG ' ' A' ' 153' ' ' PHE . 41.8 Cg_endo -89.71 -74.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.183 2.588 . . . . 0.0 112.873 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.766 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.7 p90 58.2 162.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.394 0.434 . . . . 0.0 111.052 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -110.09 179.79 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.381 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 131.98 49.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.138 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 85.05 46.76 5.51 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -131.05 132.42 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 137' ' ' VAL . 11.6 mm -94.68 121.4 45.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.993 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.611 ' H ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.39 161.99 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.687 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.435 ' CD ' ' C ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -103.68 88.15 3.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.052 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 172' ' ' ALA . 23.1 mm -56.6 112.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.66 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -77.93 -31.14 50.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.886 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.598 ' OD2' HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -177.79 161.65 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.206 0.527 . . . . 0.0 112.116 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.562 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -101.51 83.93 0.49 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.864 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.788 ' HB3' HG12 ' A' ' 127' ' ' VAL . 24.8 Cg_endo -64.43 -33.79 56.48 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.436 1.424 . . . . 0.0 110.538 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.49 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -156.23 -167.77 2.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.047 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.455 ' O ' HG11 ' A' ' 184' ' ' VAL . 0.5 OUTLIER -95.68 -11.72 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.12 178.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.485 ' O ' ' HD2' ' A' ' 185' ' ' PRO . 6.2 pt20 -91.92 -32.22 15.36 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.785 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.791 ' CA ' HG23 ' A' ' 184' ' ' VAL . 0.5 OUTLIER -142.68 141.88 31.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.593 0.711 . . . . 0.0 111.961 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.66 ' HA ' ' HD2' ' A' ' 165' ' ' PRO . 38.0 m0 -124.94 103.13 7.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.748 ' OD1' HG21 ' A' ' 127' ' ' VAL . 0.2 OUTLIER -36.4 122.18 0.74 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 161' ' ' ILE . . . -150.88 163.39 38.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.279 0.562 . . . . 0.0 111.841 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 179' ' ' ARG . 4.2 tt0 -115.39 154.06 29.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.177 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' HB2' HD11 ' A' ' 151' ' ' LEU . 48.4 t0 -96.01 155.4 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.157 0.503 . . . . 0.0 110.952 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 p -59.49 0.39 0.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.842 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.65 -32.08 15.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.894 0.378 . . . . 0.0 110.326 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 134.31 -23.89 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HD2' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.35 158.97 25.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.647 ' HA ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -136.36 178.57 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 111.726 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.79 -163.52 34.2 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.617 ' CE ' ' N ' ' A' ' 171' ' ' ASN . 4.9 mmm -97.32 120.25 37.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 151' ' ' LEU . 34.4 pt -93.99 167.02 14.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.337 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 28.1 Cg_endo -86.62 110.78 0.94 Allowed 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.608 2.205 . . . . 0.0 110.067 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.791 HG23 ' CA ' ' A' ' 169' ' ' TRP . 32.7 t -59.41 -56.76 32.63 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.711 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 184' ' ' VAL . 38.2 Cg_endo -66.65 10.0 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.943 1.762 . . . . 0.0 112.765 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 2.7 m-85 -117.56 -21.94 8.34 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.715 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.4 m -117.75 -171.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.717 ' O ' HG12 ' A' ' 137' ' ' VAL . 9.8 pt-20 -155.36 -176.44 5.94 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.238 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 135.02 34.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -150.35 126.99 10.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.89 0.376 . . . . 0.0 110.767 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -116.69 92.98 39.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.78 -42.01 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.553 2.169 . . . . 0.0 111.742 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -179.42 34.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.8 t -153.32 47.24 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.72 24.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.477 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.54 -174.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.018 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.63 -174.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.091 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.59 175.83 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -158.73 -45.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.027 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 132' ' ' GLU . 0.4 OUTLIER 77.67 -53.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.224 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.41 -30.32 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -94.49 22.39 37.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.593 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.44 90.03 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -112.38 -175.8 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.72 29.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 58.37 68.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.29 -133.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -111.02 -30.32 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.636 ' N ' ' CD ' ' A' ' 210' ' ' PRO . 19.1 p-80 -82.21 -29.65 0.49 Allowed Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 209' ' ' HIS . 63.8 Cg_endo -83.46 -57.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 60.76 149.95 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.89 178.8 5.98 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.77 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 153.52 156.66 7.72 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -50.26 115.05 2.9 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.68 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.7 155.87 66.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.502 2.135 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' N ' ' HD3' ' A' ' 218' ' ' PRO . 0.5 OUTLIER -142.02 60.93 11.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.888 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 217' ' ' GLU . 24.6 Cg_exo -63.29 67.15 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.992 2.461 . . . . 0.0 112.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 217' ' ' GLU . . . -153.55 -177.09 26.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.323 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.46 160.76 46.0 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.444 2.096 . . . . 0.0 112.247 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PTR . . . . . 0.565 ' HD1' ' N ' ' A' ' 221' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 61.53 -162.95 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -156.93 131.57 5.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.758 ' HB3' HD13 ' A' ' 109' ' ' LEU . 2.2 Cg_endo -51.65 -22.89 13.98 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.927 1.752 . . . . 0.0 112.454 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.427 ' CB ' ' CB ' ' A' ' 91' ' ' ASP . 12.9 m -114.15 111.91 22.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 227' ' ' ASN . 6.6 m -124.36 -45.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.07 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 226' ' ' VAL . 7.6 t30 -147.41 28.86 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.902 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 3.2 tpt . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.855 0.36 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 71.88 -61.25 0.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.25 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.05 51.06 0.83 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.356 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.06 38.66 1.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.887 0.375 . . . . 0.0 110.947 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -120.77 117.7 28.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.97 166.31 13.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -94.27 -15.36 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.244 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 31.01 6.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.716 0.294 . . . . 0.0 111.549 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -108.44 -18.85 13.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.792 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 40.08 32.84 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.196 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -132.56 -42.18 0.94 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -31.87 10.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.414 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.803 ' CZ3' HG21 ' A' ' 37' ' ' VAL . 14.7 p-90 -93.23 -15.44 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.505 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.683 ' HA ' HG23 ' A' ' 37' ' ' VAL . 11.0 t80 -112.61 112.45 23.98 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.758 0.314 . . . . 0.0 111.326 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.779 ' CG ' HD12 ' A' ' 18' ' ' LEU . 15.6 m95 -79.48 -17.38 54.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.616 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.59 -107.78 3.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 58.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 111.19 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -79.79 141.22 36.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -61.42 146.44 48.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -22.23 61.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.517 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 1.6 pt20 -96.71 -25.69 15.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.851 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.5 mm-40 -89.63 -22.43 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.179 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.868 ' HA ' HD13 ' A' ' 18' ' ' LEU . . . -79.06 -21.67 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.983 0.421 . . . . 0.0 110.859 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.844 HG23 HG13 ' A' ' 57' ' ' VAL . 7.6 p -102.91 -27.3 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.047 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 21' ' ' GLN . . . -60.42 -33.12 72.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.395 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -95.44 -45.3 7.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.165 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.858 ' N ' HD22 ' A' ' 26' ' ' LEU . 25.6 tp -63.76 -53.94 43.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 110.767 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -55.65 110.99 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.386 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.02 36.23 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.76 -0.733 . . . . 0.0 114.389 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.826 ' HG3' HG23 ' A' ' 118' ' ' VAL . 12.9 mm-40 -69.16 -60.32 2.43 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.925 0.862 . . . . 0.0 111.435 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.511 ' HG2' HG23 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -159.04 -148.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.009 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.72 -35.07 67.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.739 0.304 . . . . 0.0 110.997 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.812 ' HA3' HG21 ' A' ' 115' ' ' ILE . . . -150.37 125.45 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.791 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.647 ' CG1' ' HB ' ' A' ' 118' ' ' VAL . 22.0 t -156.04 158.83 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.883 ' CE2' HD11 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -158.04 162.59 38.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.958 0.409 . . . . 0.0 111.487 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.848 HD21 ' O ' ' A' ' 23' ' ' ALA . 3.6 pp -154.08 -169.32 3.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.217 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.803 HG21 ' CZ3' ' A' ' 13' ' ' TRP . 0.1 OUTLIER -146.83 137.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.731 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.667 ' HB2' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -117.53 -174.14 2.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.67 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -120.18 -2.1 10.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.614 0.245 . . . . 0.0 111.095 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t 57.15 110.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.031 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.4 m -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.17 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.8 m -71.81 -33.89 68.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.45 67.95 0.93 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.597 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.51 -29.61 79.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.69 2.26 . . . . 0.0 112.214 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.12 -18.52 60.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.469 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 6.9 m-20 -109.01 127.94 54.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.01 163.19 15.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.044 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.796 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -129.62 155.92 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.612 HD11 ' CG1' ' A' ' 51' ' ' VAL . 1.7 tm? -120.82 118.4 29.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.547 ' OG ' HG21 ' A' ' 57' ' ' VAL . 7.4 t -103.65 141.37 36.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.25 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.1 m -140.45 94.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.151 0.5 . . . . 0.0 112.206 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.0 t -35.84 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.408 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.51 -82.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.881 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -109.81 -142.23 0.38 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' ASN . 0.3 OUTLIER -33.41 -68.21 0.11 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.172 0.442 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -164.75 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 24' ' ' VAL . 26.5 m -99.73 -152.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.29 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -134.81 88.63 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.237 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 221' ' ' PTR . 14.7 p80 -66.53 119.15 11.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.44 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.603 ' CD1' ' HD3' ' A' ' 224' ' ' PRO . 30.0 m-85 -123.97 126.17 45.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.053 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.533 HG12 ' CG ' ' A' ' 221' ' ' PTR . 0.0 OUTLIER -87.99 121.41 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.371 0.605 . . . . 0.0 111.757 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 49' ' ' LEU . 2.4 mp -98.15 162.56 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.113 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.456 ' N ' HG22 ' A' ' 62' ' ' ILE . 3.4 m-80 -131.99 129.36 40.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 111.397 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.22 89.13 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.515 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -75.1 -6.42 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 86' ' ' ARG . . . 65.06 136.84 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.178 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.36 87.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.499 2.133 . . . . 0.0 112.328 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -149.13 123.37 4.72 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.61 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.2 Cg_exo -58.99 -175.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.218 1.945 . . . . 0.0 111.789 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.805 ' O ' HG13 ' A' ' 71' ' ' VAL . 69.0 Cg_endo -83.53 102.28 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.58 2.187 . . . . 0.0 113.345 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 70' ' ' PRO . 2.1 m 102.33 -41.3 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.031 1.332 . . . . 0.0 113.799 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.769 ' HD3' HG22 ' A' ' 71' ' ' VAL . 44.0 Cg_endo -91.21 167.49 3.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.994 1.796 . . . . 0.0 112.633 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.39 -47.33 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.528 2.152 . . . . 0.0 112.264 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 1.3 m 172.63 65.44 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 74' ' ' SER . 7.5 Cg_exo -72.97 -42.01 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.775 2.317 . . . . 0.0 112.397 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.08 98.39 6.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.605 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.661 ' HB2' ' HD3' ' A' ' 78' ' ' PRO . 25.1 mm-40 -160.99 -59.33 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 77' ' ' GLN . 63.1 Cg_exo -50.78 -50.65 13.11 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.211 1.941 . . . . 0.0 113.627 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 78' ' ' PRO . 2.2 Cg_endo -43.13 -59.84 0.91 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.934 2.423 . . . . 0.0 113.874 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 36.8 Cg_endo -64.6 -19.28 64.76 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.186 1.924 . . . . 0.0 112.633 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.17 -54.18 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.954 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.2 m -76.52 87.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.237 0.541 . . . . 0.0 110.831 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 t -113.07 103.4 55.64 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.628 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.43 167.03 25.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.541 2.16 . . . . 0.0 112.458 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.82 -171.72 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB2' ' N ' ' A' ' 66' ' ' GLY . 29.6 mmt180 -126.72 104.03 7.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.779 ' CD1' HD21 ' A' ' 100' ' ' LEU . 2.9 tm? -149.29 117.43 6.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.757 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . 21.3 ttp180 -131.4 134.13 45.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.468 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.892 HG23 ' H ' ' A' ' 90' ' ' GLY . 8.9 tt -91.98 -96.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.156 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.892 ' H ' HG23 ' A' ' 89' ' ' ILE . . . -84.63 -77.34 1.17 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.932 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' CB ' ' CB ' ' A' ' 225' ' ' SER . 23.1 t70 -120.56 -32.25 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 110.945 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.89 132.1 38.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -124.02 159.95 28.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.307 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -147.27 -115.79 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.58 -69.26 0.83 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.846 0.355 . . . . 0.0 111.034 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 m -125.29 -162.11 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.722 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 87' ' ' LEU . 1.4 mm? -74.95 -62.18 0.92 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.784 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.479 ' HD3' ' CZ2' ' A' ' 13' ' ' TRP . 4.4 Cg_endo -46.66 -23.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.887 2.391 . . . . 0.0 112.426 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.79 -33.98 69.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.779 HD21 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -97.22 -7.16 32.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.593 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.769 HD11 ' CZ3' ' A' ' 13' ' ' TRP . 23.2 mt -76.73 -35.82 57.54 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.462 0.649 . . . . 0.0 109.614 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -12.12 49.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -77.59 -23.44 49.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.421 ' CG ' ' HB3' ' A' ' 109' ' ' LEU . 66.8 m-85 -119.64 19.01 12.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.332 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -63.21 -20.71 65.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.69 HD13 ' N ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -156.45 33.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.602 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.73 -6.21 8.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.177 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 111' ' ' THR . 0.4 OUTLIER 63.23 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.661 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.805 HD12 ' H ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -77.36 -44.18 30.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.825 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.805 ' H ' HD12 ' A' ' 109' ' ' LEU . 3.3 t0 -139.69 -17.06 0.99 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 110' ' ' ASP . 8.6 t 139.46 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.401 0.68 . . . . 0.0 110.204 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 51' ' ' VAL . 1.2 t 170.6 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.424 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER 61.27 157.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.883 HD11 ' CE2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -89.64 136.22 33.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.195 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.858 HG22 ' H ' ' A' ' 116' ' ' GLU . 2.5 mm -121.25 -158.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.122 0.487 . . . . 0.0 111.72 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.858 ' H ' HG22 ' A' ' 115' ' ' ILE . 5.7 pt-20 -81.15 158.29 69.9 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.295 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.38 143.1 81.63 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.177 . . . . 0.0 112.121 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.826 HG23 ' HG3' ' A' ' 30' ' ' GLN . 5.9 p -73.52 -49.49 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.555 ' N ' HG13 ' A' ' 118' ' ' VAL . 61.5 m 58.09 -165.97 0.16 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.75 -33.61 76.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.999 0.428 . . . . 0.0 109.957 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 122' ' ' ARG . 1.0 OUTLIER 66.48 -65.01 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.505 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.463 ' N ' ' OG ' ' A' ' 121' ' ' SER . 20.2 ttp-105 -174.57 -102.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.538 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.459 ' CG ' ' HG2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -140.47 -76.29 0.32 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.761 0.315 . . . . 0.0 111.03 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.47 105.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' CH2' ' A' ' 169' ' ' TRP . 14.6 p -55.45 -89.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.566 0.222 . . . . 0.0 111.165 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.43 34.9 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.58 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 165' ' ' PRO . 1.8 m -57.56 -177.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.265 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.598 HD11 ' OD2' ' A' ' 163' ' ' ASP . 1.4 pt -98.93 178.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.062 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.38 179.65 5.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 50.45 80.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.395 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.501 ' HB2' HD22 ' A' ' 200' ' ' LEU . 0.6 OUTLIER -175.88 151.23 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.897 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 200' ' ' LEU . 2.6 mm-40 -66.23 164.98 14.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -147.23 172.54 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.62 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -169.14 160.31 9.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.149 0.499 . . . . 0.0 111.872 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 33.3 tt0 -99.37 135.59 40.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.453 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.963 ' O ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER 166.55 93.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.905 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.963 HG13 ' O ' ' A' ' 136' ' ' TYR . 1.2 m 179.86 140.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.174 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.645 ' HA ' HD13 ' A' ' 158' ' ' ILE . 6.5 tpt180 -127.85 96.9 4.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.766 ' HB1' ' CE1' ' A' ' 153' ' ' PHE . . . -37.56 160.02 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.173 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.715 ' HG ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -144.36 20.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.895 -178.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -151.13 145.55 25.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.446 0.641 . . . . 0.0 112.451 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 6.3 p-10 -84.32 77.57 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.564 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -81.58 173.84 11.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.33 -39.38 2.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.026 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 107.56 150.71 16.42 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.422 ' ND2' ' HG2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -90.76 -34.82 15.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 -168.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.58 1.01 40.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.462 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 179' ' ' ARG . 9.8 pt-20 -105.04 -38.84 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.322 . . . . 0.0 110.95 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.91 165.88 3.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.752 ' HB3' HG22 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -109.67 111.82 58.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.64 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.697 ' O ' ' CG ' ' A' ' 153' ' ' PHE . 41.8 Cg_endo -89.71 -74.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.183 2.588 . . . . 0.0 112.873 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.766 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.7 p90 58.2 162.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.394 0.434 . . . . 0.0 111.052 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -110.09 179.79 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.381 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 131.98 49.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.138 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 85.05 46.76 5.51 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -131.05 132.42 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 137' ' ' VAL . 11.6 mm -94.68 121.4 45.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.993 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.611 ' H ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.39 161.99 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.687 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.435 ' CD ' ' C ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -103.68 88.15 3.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 172' ' ' ALA . 23.1 mm -56.6 112.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.66 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -77.93 -31.14 50.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.886 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.598 ' OD2' HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -177.79 161.65 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.206 0.527 . . . . 0.0 112.116 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.562 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -101.51 83.93 0.49 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.864 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.788 ' HB3' HG12 ' A' ' 127' ' ' VAL . 24.8 Cg_endo -64.43 -33.79 56.48 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.436 1.424 . . . . 0.0 110.538 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.49 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -156.23 -167.77 2.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.047 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.455 ' O ' HG11 ' A' ' 184' ' ' VAL . 0.5 OUTLIER -95.68 -11.72 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.12 178.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.485 ' O ' ' HD2' ' A' ' 185' ' ' PRO . 6.2 pt20 -91.92 -32.22 15.36 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.785 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.791 ' CA ' HG23 ' A' ' 184' ' ' VAL . 0.5 OUTLIER -142.68 141.88 31.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.593 0.711 . . . . 0.0 111.961 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.66 ' HA ' ' HD2' ' A' ' 165' ' ' PRO . 38.0 m0 -124.94 103.13 7.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.748 ' OD1' HG21 ' A' ' 127' ' ' VAL . 0.2 OUTLIER -36.4 122.18 0.74 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 161' ' ' ILE . . . -150.88 163.39 38.78 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.279 0.562 . . . . 0.0 111.841 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 179' ' ' ARG . 4.2 tt0 -115.39 154.06 29.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.177 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' HB2' HD11 ' A' ' 151' ' ' LEU . 48.4 t0 -96.01 155.4 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.157 0.503 . . . . 0.0 110.952 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 p -59.49 0.39 0.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.842 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.65 -32.08 15.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.894 0.378 . . . . 0.0 110.326 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 134.31 -23.89 3.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HD2' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.35 158.97 25.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.647 ' HA ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -136.36 178.57 6.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 111.726 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.79 -163.52 34.2 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.617 ' CE ' ' N ' ' A' ' 171' ' ' ASN . 4.9 mmm -97.32 120.25 37.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.03 0.443 . . . . 0.0 110.449 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.752 HG22 ' HB3' ' A' ' 151' ' ' LEU . 34.4 pt -93.99 167.02 14.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.337 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 28.1 Cg_endo -86.62 110.78 0.94 Allowed 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.608 2.205 . . . . 0.0 110.067 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.791 HG23 ' CA ' ' A' ' 169' ' ' TRP . 32.7 t -59.41 -56.76 32.63 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.711 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 184' ' ' VAL . 38.2 Cg_endo -66.65 10.0 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.943 1.762 . . . . 0.0 112.765 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 2.7 m-85 -117.56 -21.94 8.34 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.715 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.4 m -117.75 -171.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.717 ' O ' HG12 ' A' ' 137' ' ' VAL . 9.8 pt-20 -155.36 -176.44 5.94 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.238 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 135.02 34.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -150.35 126.99 10.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.89 0.376 . . . . 0.0 110.767 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -116.69 92.98 39.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.78 -42.01 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.553 2.169 . . . . 0.0 111.742 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -179.42 34.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 33.8 t -153.32 47.24 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.72 24.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.477 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.54 -174.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.018 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.63 -174.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.091 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.59 175.83 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -158.73 -45.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.027 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 132' ' ' GLU . 0.4 OUTLIER 77.67 -53.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.224 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.41 -30.32 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -94.49 22.39 37.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.593 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.44 90.03 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.481 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -112.38 -175.8 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.72 29.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 58.37 68.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.29 -133.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -111.02 -30.32 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.636 ' N ' ' CD ' ' A' ' 210' ' ' PRO . 19.1 p-80 -82.21 -29.65 0.49 Allowed Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 209' ' ' HIS . 63.8 Cg_endo -83.46 -57.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 60.76 149.95 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.89 178.8 5.98 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.77 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 153.52 156.66 7.72 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -50.26 115.05 2.9 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.68 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.7 155.87 66.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.502 2.135 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.524 ' N ' ' HD3' ' A' ' 218' ' ' PRO . 0.5 OUTLIER -142.02 60.93 11.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.888 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 217' ' ' GLU . 24.6 Cg_exo -63.29 67.15 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.992 2.461 . . . . 0.0 112.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 217' ' ' GLU . . . -153.55 -177.09 26.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.323 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.46 160.76 46.0 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.444 2.096 . . . . 0.0 112.247 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PTR . . . . . 0.565 ' HD1' ' N ' ' A' ' 221' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 61.53 -162.95 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -156.93 131.57 5.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.758 ' HB3' HD13 ' A' ' 109' ' ' LEU . 2.2 Cg_endo -51.65 -22.89 13.98 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.927 1.752 . . . . 0.0 112.454 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.427 ' CB ' ' CB ' ' A' ' 91' ' ' ASP . 12.9 m -114.15 111.91 22.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 227' ' ' ASN . 6.6 m -124.36 -45.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.07 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 226' ' ' VAL . 7.6 t30 -147.41 28.86 0.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.811 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.902 -179.97 . . . . . . . . 0 0 . 1 stop_ save_